4 References 16. Read DJ. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med. 1967; 16: 20–32 doi: 10.1111/imj.1967.16.issue-1. 17. Rebuck AS. Measurement of ventilatory response to CO2 by rebreathing. Chest. 1976; 70: 118–121 doi: 10.1378/chest.70.1˙Supplement.118. 18. Florian J et al. Effect of paroxetine or quetiapine combined with oxycodone on ventilation: a randomized clinical trial. JAMA. 2022; 328: 1405–1414 doi: 10.1001/jama.2022.17735. 19. Henriques BC et al. Methodology for clinical genotyping of CYP2D6 and CYP2C19. Transl Psychiatry. 2021; 11: 596 (2022 corrected version) doi: 10.1038/s41398-021-01717-9. 20. Schrier R van der, Roozekrans M, Olofsen E, Aarts L, Velzen M van, Jong M de, Dahan A, Niesters M. Influence of ethanol on oxycodoneinduced respiratory depression: a dose-escalating study in young and elderly volunteers. Anesthesiology. 2017; 126: 534–542 doi: 10.1097/ALN.0000000000001505. 21. Romberg R, Olofsen E, Sarton E, Teppema L, Dahan A. Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers. Anesthesiology. 2003; 99: 788– 789 doi: 10.1097/00000542-200310000-00008. 22. Holford NH. A size standard for pharmacokinetics. Clin Pharmacokinet. 1996; 30: 329–332 doi: 10.2165/00003088-199630050-00001. 23. Schrier Rvd, Jonkman K, Velzen Mv, Olofsen E, Drewes AM, Dahan A, Niesters M. An experimental study comparing the respiratory effects of tapentadol and oxycodone in healthy volunteers. Br J Anaesth. 2017; 119: 1169–1177 doi: 10.1093/bja/aex295. 24. Minto CF, Schnider TW, Gregg KM, Henthorn TK, Shafer SL. Using the maximum effect site concentration to combine pharmacokinetics and dynamics. Anesthesiology. 2003; 99: 324–333 doi: 10.1097/00000542-200308000-00014. 25. Caudle KE, Sangkuhl K, Whirl-Carrillo M, Swen JJ, Haider CE, Klein TE, Gammal RS, Relling MV, Scott SA, Hertz DL, Guchelaar HJ, Gaedigk A. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and Dutch pharmacogenetics working group. Clin Transl Sci. 95
RkJQdWJsaXNoZXIy MTk4NDMw